Before lockdown | First lockdown month | p value | 95%-CI | d | |
---|---|---|---|---|---|
Monthly headache days (MHD) | 7.01 ± 5.64 | 6.89 ± 5.47 | > 0.999 | −0.03 – 0.27 | 0.022 |
Monthly migraine days (MMD) | 4.98 ± 4.97 | 4.95 ± 4.83 | > 0.999 | −0.11 – 0.16 | 0.006 |
Monthly days with acute medication use (AMD) | 4.50 ± 3.88 | 4.27 ± 3.81 | < 0.001* | 0.19–0.35 | 0.060 |
Migraine pain intensity (NRS 0–10) | 5.30 ± 1.77 | 5.35 ± 1.75 | > 0.999 | −0.10 – 0.01 | 0.028 |
Headache intensity (NRS 0–10) | 4.90 ± 1.71 | 4.92 ± 1.72 | > 0.999 | −0.09 – 0.01 | 0.011 |
Activity Level (NRS 0–10) | 4.82 ± 1.56 | 4.76 ± 1.62 | 0.001* | 0.03–0.09 | 0.038 |
Energy Level (NRS 0–10) | 5.28 ± 1.42 | 5.34 ± 1.47 | < 0.001* | −0.08 – − 0.04 | 0.041 |
Mood (NRS 0–4) | 2.42 ± 0.53 | 2.45 ± 0.56 | < 0.001* | −0.04 – − 0.02 | 0.055 |
Stress level (NRS 0–10) | 3.81 ± 1.83 | 3.38 ± 1.86 | < 0.001* | 0.40–0.46 | 0.233 |
Sleep duration (h) | 7.68 ± 0.79 | 7.87 ± 0.82 | < 0.001* | −0.20 – − 0.17 | 0.236 |
Sleep quality (NRS 0–10) | 5.96 ± 1.57 | 5.97 ± 1.61 | > 0.999 | −0.03 – 0.01 | 0.006 |